123
Views
22
CrossRef citations to date
0
Altmetric
RADIATION ONCOLOGY

Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting

, Ph.D. & , Sc.D., M.D.
Pages 82-97 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David M Goldenberg & Robert M Sharkey. (2012) Using antibodies to target cancer therapeutics. Expert Opinion on Biological Therapy 12:9, pages 1173-1190.
Read now
Vladimir Tolmachev, Anna Orlova, Fredrik Y Nilsson, Joachim Feldwisch, Anders Wennborg & Lars Abrahmsén. (2007) Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy. Expert Opinion on Biological Therapy 7:4, pages 555-568.
Read now

Articles from other publishers (20)

Sarah M. Cheal, Sebastian K. Chung, Brett A. Vaughn, Nai-Kong V. Cheung & Steven M. Larson. (2022) Pretargeting: A Path Forward for Radioimmunotherapy. Journal of Nuclear Medicine 63:9, pages 1302-1315.
Crossref
Maryana Handula, Kuo-Ting Chen & Yann Seimbille. (2021) IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications. Molecules 26:15, pages 4640.
Crossref
Guozheng Liu. (2018) A Revisit to the Pretargeting Concept—A Target Conversion. Frontiers in Pharmacology 9.
Crossref
Brian M. Zeglis, Christian Brand, Dalya Abdel-Atti, Kathryn E. Carnazza, Brendon E. Cook, Sean Carlin, Thomas Reiner & Jason S. Lewis. (2015) Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. Molecular Pharmaceutics 12:10, pages 3575-3587.
Crossref
Steven M. Larson, Jorge A. Carrasquillo, Nai-Kong V. Cheung & Oliver W. Press. (2015) Radioimmunotherapy of human tumours. Nature Reviews Cancer 15:6, pages 347-360.
Crossref
Maria Corinna Palanca-Wessels & Oliver W. Press. (2014) Advances in the treatment of hematologic malignancies using immunoconjugates. Blood 123:15, pages 2293-2301.
Crossref
Brian M. Zeglis, Kuntal K. Sevak, Thomas Reiner, Priya Mohindra, Sean D. Carlin, Pat Zanzonico, Ralph Weissleder & Jason S. Lewis. (2013) A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry. Journal of Nuclear Medicine 54:8, pages 1389-1396.
Crossref
Johannes Meller, Torsten Liersch, Birgit Meller, Kia Homayounfar & Carsten-Oliver Sahlmann. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 639 661 .
Berrin Erdag, B. Koray Balcioglu, Aylin Ozdemir Bahadir, Muge Serhatli, Omer Kacar, Aydin Bahar, Urartu O. S. Seker, Emel Akgun, Abdulkadir Ozkan, Turker Kilic, Candan Tamerler & Kemal Baysal. (2011) Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2. Biotechnology and Applied Biochemistry 58:6, pages 412-422.
Crossref
David Boas, Constantinos Pitris & Nimmi RamanujamWalter Akers & Samuel Achilefu. 2011. Handbook of Biomedical Optics. Handbook of Biomedical Optics 673 696 .
David M. Goldenberg. (2010) Introduction to the supplement, “Cancer Therapy with Antibodies and Immunoconjugates”. Cancer 116:S4, pages 1011-1012.
Crossref
Serengulam V. Govindan & David M. Goldenberg. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 371 392 .
Frederic Zoller, Michael Eisenhut, Uwe Haberkorn & Walter Mier. (2009) Endoradiotherapy in cancer treatment — Basic concepts and future trends. European Journal of Pharmacology 625:1-3, pages 55-62.
Crossref
Guozheng Liu & Donald J. Hnatowich. (2008) A Semiempirical Model of Tumor Pretargeting. Bioconjugate Chemistry 19:11, pages 2095-2104.
Crossref
Guozheng Liu, Shuping Dou, Mary Rusckowski & Donald J. Hnatowich. (2008) An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector. Molecular Cancer Therapeutics 7:5, pages 1025-1032.
Crossref
Robert M. Sharkey, Habibe Karacay, Shankar Vallabhajosula, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Stanley J. Goldsmith & David M. Goldenberg. (2008) Metastatic Human Colonic Carcinoma: Molecular Imaging with Pretargeted SPECT and PET in a Mouse Model. Radiology 246:2, pages 497-507.
Crossref
David M. Goldenberg, Edmund A. Rossi, Robert M. Sharkey, William J. McBride & Chien-Hsing Chang. (2008) Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting. Journal of Nuclear Medicine 49:1, pages 158-163.
Crossref
D M Goldenberg & R M Sharkey. (2007) Novel radiolabeled antibody conjugates. Oncogene 26:25, pages 3734-3744.
Crossref
Vladimir Tolmachev, Anna Orlova, Rikard Pehrson, Joakim Galli, Barbro Baastrup, Karl Andersson, Mattias Sandström, Daniel Rosik, Jörgen Carlsson, Hans Lundqvist, Anders Wennborg & Fredrik Y. Nilsson. (2007) Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule. Cancer Research 67:6, pages 2773-2782.
Crossref
Maneesh Jain, Ganesh Venkatraman & Surinder K. Batra. (2007) Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation. Clinical Cancer Research 13:5, pages 1374-1382.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.